Colon-Thillet R, Jerome KR, Stone D. Optimization of AAV vectors to target persistent viral reservoirs. Virol J. 2021;18:85.
Article CAS PubMed PubMed Central Google Scholar
Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358–78.
Article CAS PubMed PubMed Central Google Scholar
Hudry E, Vandenberghe LH. Therapeutic AAV gene transfer to the nervous system: a clinical reality. Neuron. 2019;101:839–62.
Article CAS PubMed Google Scholar
Morris JA, Boshoff CH, Schor NF, Wong LM, Gao G, Davidson BL. Next-generation strategies for gene-targeted therapies of central nervous system disorders: a workshop summary. Mol Ther. 2021;29:3332–44.
Article CAS PubMed PubMed Central Google Scholar
Schuster DJ, Dykstra JA, Riedl MS, Kitto KF, Belur LR, McIvor RS, et al. Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse. Front Neuroanat. 2014;8:42.
Article PubMed PubMed Central Google Scholar
Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum Gene Ther. 2018;29:285–98.
Article CAS PubMed PubMed Central Google Scholar
Hordeaux J, Buza EL, Dyer C, Goode T, Mitchell TW, Richman L, et al. Adeno-associated virus-induced dorsal root ganglion pathology. Hum Gene Ther. 2020;31:808–18.
Article CAS PubMed Google Scholar
Hordeaux J, Buza EL, Jeffrey B, Song C, Jahan T, Yuan Y, et al. MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates. Sci Transl Med. 2020;12:eaba9188.
Article CAS PubMed Google Scholar
Hordeaux J, Hinderer C, Buza EL, Louboutin JP, Jahan T, Bell P, et al. Safe and sustained expression of human iduronidase after intrathecal administration of adeno-associated virus serotype 9 in infant Rhesus monkeys. Hum Gene Ther. 2019;30:957–66.
Article CAS PubMed PubMed Central Google Scholar
Hordeaux J, Hinderer C, Goode T, Buza EL, Bell P, Calcedo R, et al. Toxicology study of intra-cisterna magna adeno-associated virus 9 expressing iduronate-2-sulfatase in Rhesus macaques. Mol Ther Methods Clin Dev. 2018;10:68–78.
Article CAS PubMed PubMed Central Google Scholar
Hordeaux J, Hinderer C, Goode T, Katz N, Buza EL, Bell P, et al. Toxicology study of intra-cisterna magna adeno-associated virus 9 expressing human alpha-L-iduronidase in Rhesus macaques. Mol Ther Methods Clin Dev. 2018;10:79–88.
Article CAS PubMed PubMed Central Google Scholar
Hordeaux J, Wang Q, Katz N, Buza EL, Bell P, Wilson JM. The neurotropic properties of AAV-PHP.B are limited to C57BL/6J mice. Mol Ther. 2018;26:664–8.
Article CAS PubMed PubMed Central Google Scholar
Bolt MW, Brady JT, Whiteley LO, Khan KN. Development challenges associated with rAAV-based gene therapies. J Toxicol Sci. 2021;46:57–68.
Article CAS PubMed Google Scholar
EMA. Zolgensma assessment report. https://www.ema.europa.eu/en/documents/assessment-report/zolgensma-epar-public-assessment-report_en.pdf, 2020.
Palazzi X, Pardo ID, Sirivelu MP, Newman L, Kumpf SW, Qian J, et al. Biodistribution and tolerability of AAV-PHP.B-CBh-SMN1 in wistar han rats and cynomolgus macaques reveal different toxicologic profiles. Hum Gene Ther. 2022;33:175–87.
Article CAS PubMed PubMed Central Google Scholar
Hinderer C, Bell P, Louboutin JP, Katz N, Zhu Y, Lin G, et al. Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model. Mol Genet Metab. 2016;119:124–30.
Article CAS PubMed PubMed Central Google Scholar
Marco S, Haurigot V, Jaen ML, Ribera A, Sanchez V, Molas M, et al. Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal. Mol Ther Methods Clin Dev. 2021;23:370–89.
Article CAS PubMed PubMed Central Google Scholar
Hordeaux J, Jeffrey BA, Jian J, Choudhury GR, Michalson K, Mitchell TW, et al. Efficacy and safety of a krabbe disease gene therapy. Hum Gene Ther. 2022.
Buss N, Lanigan L, Zeller J, Cissell D, Metea M, Adams E, et al. Characterization of AAV-mediated dorsal root ganglionopathy. Mol Ther Methods Clin Dev. 2022;24:342–54.
Article CAS PubMed PubMed Central Google Scholar
Fader KA, Pardo ID, Kovi RC, Somps CJ, Wang HH, Vaidya VS, et al. Circulating neurofilament light chain as a promising biomarker of AAV-induced dorsal root ganglia toxicity in nonclinical toxicology species. Mol Ther Methods Clin Dev. 2022;25:264–77.
Article CAS PubMed PubMed Central Google Scholar
Johnston S, Parylak SL, Kim S, Mac N, Lim C, Gallina I, et al. AAV ablates neurogenesis in the adult murine hippocampus. Elife. 2021;10:e59291.
Article CAS PubMed PubMed Central Google Scholar
Ciesielska A, Hadaczek P, Mittermeyer G, Zhou S, Wright JF, Bankiewicz KS, et al. Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Mol Ther. 2013;21:158–66.
Article CAS PubMed Google Scholar
Klein RL, Dayton RD, Leidenheimer NJ, Jansen K, Golde TE, Zweig RM. Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol Ther. 2006;13:517–27.
Article CAS PubMed Google Scholar
Samaranch L, Sebastian WS, Kells AP, Salegio EA, Heller G, Bringas JR, et al. AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction. Mol Ther. 2014;22:329–37.
Article CAS PubMed PubMed Central Google Scholar
Zerah M, Piguet F, Colle MA, Raoul S, Deschamps JY, Deniaud J, et al. Intracerebral gene therapy using AAVrh.10-hARSA recombinant vector to treat patients with early-onset forms of metachromatic leukodystrophy: preclinical feasibility and safety assessments in nonhuman primates. Hum Gene Ther Clin Dev. 2015;26:113–24.
Article CAS PubMed Google Scholar
Crystal R. Clinical and nonclinical consequences of direct CNS parenchymal administration of AAV vectors: https://www.fda.gov/media/151998/download, 2021.
Rosenberg JB, Chen A, De BP, Dyke JP, Ballon DJ, Monette S, et al. Safety of direct intraparenchymal AAVrh.10-mediated central nervous system gene therapy for metachromatic leukodystrophy. Hum Gene Ther. 2021;32:563–80.
Article CAS PubMed PubMed Central Google Scholar
Golebiowski D, van der Bom IMJ, Kwon CS, Miller AD, Petrosky K, Bradbury AM, et al. Direct intracranial injection of AAVrh8 encoding monkey beta-N-acetylhexosaminidase causes neurotoxicity in the primate brain. Hum Gene Ther. 2017;28:510–22.
Article CAS PubMed PubMed Central Google Scholar
Keiser MS, Ranum PT, Yrigollen CM, Carrell EM, Smith GR, Muehlmatt AL, et al. Toxicity after AAV delivery of RNAi expression constructs into nonhuman primate brain. Nat Med. 2021;27:1982–9.
Article CAS PubMed PubMed Central Google Scholar
Davidson MK, Lindsey JR, Davis JK. Requirements and selection of an animal model. Isr J Med Sci. 1987;23:551–5.
Eaton SL, Wishart TM. Bridging the gap: large animal models in neurodegenerative research. Mamm Genome. 2017;28:324–37.
Article CAS PubMed PubMed Central Google Scholar
Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006;12:342–7.
Article CAS PubMed Google Scholar
Kuzmin DA, Shutova MV, Johnston NR, Smith OP, Fedorin VV, Kukushkin YS, et al. The clinical landscape for AAV gene therapies. Nat Rev Drug Discov. 2021;20:173–4.
Article CAS PubMed Google Scholar
Chand DH, Zaidman C, Arya K, Millner R, Farrar MA, Mackie FE, et al. Thrombotic microangiopathy following onasemnogene abeparvovec for spinal muscular atrophy: a case series. J Pediatr. 2021;231:265–8.
Article CAS PubMed Google Scholar
Feldman AG, Parsons JA, Dutmer CM, Veerapandiyan A, Hafberg E, Maloney N, et al. Subacute liver failure following gene replacement therapy for spinal muscular atrophy type 1. J Pediatr. 2020;225:252–8 e1.
Article CAS PubMed PubMed Central Google Scholar
High-dose AAV gene therapy deaths. Nat Biotechnol. 2020; 38:910. https://doi.org/10.1038/s41587-020-0642-9
留言 (0)